Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

Zimmer Biomet Holdings, Inc. (ZBH) Interest Coverage Ratio: 4.65x

The interest coverage ratio for Zimmer Biomet Holdings, Inc. (ZBH) is 4.65x as of Saturday, June 20, 2026.

ZBH Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

4.65x

ZBH Competitors' Interest Coverage Ratio

NAMEMARKET CAPINTEREST COVERAGE RATIOTTM3Y5Y
Zimmer Biomet Holdings, Inc. (ZBH)$17.02B4.65xN/AN/AN/A
Hologic, Inc. (HOLX)vs ›$16.97B16.73x11.98x11.81x13.87x
DaVita Inc. (DVA)vs ›$13.34B3.66x4.05x3.97x4.62x
Medpace Holdings, Inc. (MEDP)vs ›$13.14BN/A393.08x892.58x554.26x
Solventum Corporation (SOLV)vs ›$13.06B6.29x4.55x4.55x4.55x
Labcorp Holdings Inc. (LH)vs ›$20.98B6.77x5.99x5.91x8.30x
Align Technology, Inc. (ALGN)vs ›$13.04BN/A67.41x66.08x407.22x
The Cooper Companies, Inc. (COO)vs ›$12.85B6.83x6.50x6.73x9.55x
United Therapeutics Corporation (UTHR)vs ›$22.78B77.81x54.95x40.03x35.88x
Revvity, Inc. (RVTY)vs ›$11.16B3.87x4.06x4.92x8.88x

Financial Health Indicators

Interest Coverage

4.7x

Debt/Equity

0.59

Current Ratio

1.98

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

  • < 1.5x: EBIT is less than 1.5 times interest expense
  • 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
  • 3x - 5x: EBIT is between 3 and 5 times interest expense
  • > 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Zimmer Biomet Holdings, Inc. Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Zimmer Biomet Holdings, Inc. Interest Coverage Ratio FAQ

What is the interest coverage ratio for Zimmer Biomet Holdings, Inc. (ZBH)?
The interest coverage ratio for ZBH stock is 4.65x.

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos